SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
Score window: May. 30, 2025 to May. 29, 2026

Probe Score
4.5 / 10
Letters
4
Latest Activity
Aug. 7, 2025
Version
v1

Score Breakdown

Letter Count
3.0
Sentiment / Tone
1.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Aug. 7, 2025 UPLOAD Neutral/Informational Low The SEC has completed its review of Lixte Biotechnology Holdings, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. The correspondence emphasizes that the responsibili… Read Filing EDGAR
Jul. 24, 2025 CORRESP Concern from SEC Moderate Lixte Biotechnology Holdings, Inc. has responded to comments from the SEC regarding its Form 10-K for the fiscal year ended December 31, 2024. The SEC raised concerns about the co… Read Filing EDGAR
Jul. 16, 2025 UPLOAD Concern from SEC High The SEC has reviewed Lixte Biotechnology Holdings, Inc.'s Form 10-K for the fiscal year ended December 31, 2024, and has issued several comments regarding the company's disclosure… Read Filing EDGAR
Jul. 14, 2025 CORRESP Neutral/Informational Moderate Lixte Biotechnology Holdings, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. They are seeking to h… Read Filing EDGAR
Jun. 26, 2025 CORRESP Neutral/Informational Low Lixte Biotechnology Holdings, Inc. has formally withdrawn its request for the acceleration of the effective date of its Registration Statement on Form S-1, which was initially req… Read Filing EDGAR
Jun. 24, 2025 CORRESP Neutral/Informational Moderate Lixte Biotechnology Holdings, Inc. has submitted a request for the acceleration of the effective date of their Registration Statement No. 333-288120 on Form S-1/A. The request aim… Read Filing EDGAR
Jun. 24, 2025 CORRESP Neutral/Informational Moderate Lixte Biotechnology Holdings, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking for the statem… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.